Page last updated: 2024-11-04

temozolomide and Rhabdomyosarcoma 2

temozolomide has been researched along with Rhabdomyosarcoma 2 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinoshita, M1
Yamada, A1
Sawa, D1
Kamimura, S1
Miyachi, M1
Moritake, H1
Paulino, AC1
Pappo, A1
Mixon, BA1
Eckrich, MJ1
Lowas, S1
Engel, ME1

Other Studies

3 other studies available for temozolomide and Rhabdomyosarcoma 2

ArticleYear
Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapy.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child, Preschool; C

2018
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Mod

2009
Vincristine, irinotecan, and temozolomide for treatment of relapsed alveolar rhabdomyosarcoma.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Child, Preschool; Dacarbazine;

2013